https://www.biospace.com/cresilon-closes-38-5-million-series-a-3-financing-to-accelerate-commercialization-of-hemostatic-gel
Cresilon, Inc., the Brooklyn -based biotechnology company, announced today the successful close of its Series A-3 financing, totaling $38.5 million . This...
series aclosesmillionfinancing